Trailing-twelve-month (TTM) revenue is $57.18 Million with a year-over-year growth of (4.73%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $17,454,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-10 |
| Q4 FY2025Period ended 2025-12-31 | $15,715,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-24 |
| Q1 FY2026Period ended 2026-03-31 | $11,126,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $12,885,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-12 |
| TTM revenue | $57,180,000 |
Current P/S: $326,507,136 market capitalization ÷ $57,180,000 TTM revenue = 5.71x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:15:11.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $12.88M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:18:05.537Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Segments Total | $105M | $72M | $71M | N/A | $59M | $62M |
| Services | $75M | $39M | $37M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| Canada | $6M | N/A | N/A | N/A | N/A |
| CANADA | N/A | $9M | $406,000 | N/A | N/A |
$57.18M
$57.18 Million
(4.73%)
vs. $60.02M a year ago (TTM)
(10.18%)
5 Year compound annual growth rate
1 Year
(4.73%)
3 Year
(10.72%)
5 Year
(10.18%)
10 Year
(0.02%)
15 Year
(3.42%)
20 Year
(2.16%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $61.67M | +$2.56M | +4.33% |
| 2024 | $59.12M | ($30.62M) | (34.12%) |
| 2023 | $89.73M | +$19.14M | +27.11% |
| 2022 | $70.60M | ($1.59M) | (2.21%) |
| 2021 | $72.19M | ($33.23M) | (31.52%) |
| 2020 |
TTM Growth
(4.73%)
3-Year CAGR
(10.72%)
5-Year CAGR
(10.18%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T19:18:05.537Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $24M |
| $17M |
| Treatment | $30M | $33M | $33M | $31M | $35M | $45M |
|---|
| GERMANY |
|---|
| N/A |
| $567,000 |
| $678,000 |
| N/A |
| N/A |
| ITALY | N/A | N/A | $14,000 | N/A | N/A |
|---|
| Segments Total | N/A | N/A | N/A | $59M | $62M |
|---|
| United States | $100M | N/A | N/A | N/A | N/A |
|---|
| UNITED STATES | N/A | $62M | $69M | N/A | N/A |
|---|
| $105.43M |
| +$31.97M |
| +43.52% |
| 2019 | $73.46M | +$23.92M | +48.29% |
| 2018 | $49.54M | ($230,000) | (0.46%) |
| 2017 | $49.77M | ($1.45M) | (2.83%) |
| 2016 | $51.22M | ($11.16M) | (17.90%) |
